Blood pressure excess for the early identification of gestational hypertension and preeclampsia

Hypertension
R C HermidaM Iglesias

Abstract

We have examined prospectively whether the combined approach of establishing tolerance intervals for the circadian variability of blood pressure (BP) as a function of gestational age, and then determining the so-called hyperbaric index (area of BP excess above the upper limit of the tolerance interval) by comparison of any patient's BP profile (obtained by ambulatory monitoring) with those intervals provides a high sensitivity test for the early detection of pregnant women who subsequently will develop gestational hypertension or preeclampsia. We analyzed 657 BP series from 92 women with uncomplicated pregnancies and 378 series from 60 women who developed gestational hypertension or preeclampsia. BP was sampled for about 48 hours once every 4 weeks after the first obstetric consultation. Circadian 90% tolerance limits were determined as a function of trimester of gestation from 497 series previously sampled from a reference group of 189 normotensive pregnant women. The hyperbaric index was then determined for each individual BP series in the validation sample. Sensitivity of this test for diagnosing gestational hypertension was 93% for women sampled during the first trimester of gestation and increased up to 99% in the third tr...Continue Reading

References

Aug 15, 1977·American Journal of Obstetrics and Gynecology·R H HayashiR C Franks
Jul 15, 1976·American Journal of Obstetrics and Gynecology·E W Page, R Christianson
Aug 1, 1992·Journal of Cardiovascular Pharmacology·R van HoofA Amery
Apr 30, 1992·The American Journal of Cardiology·W B White
Jul 1, 1991·American Journal of Obstetrics and Gynecology·G A Dekker, B M Sibai
Aug 1, 1988·American Journal of Obstetrics and Gynecology·L C Chesley, B M Sibai
Nov 1, 1988·Mayo Clinic Proceedings·P K ZachariahC A Carlson
Dec 1, 1988·American Journal of Obstetrics and Gynecology·J F ClappJ Hiser
Apr 1, 1987·American Journal of Obstetrics and Gynecology·R E ReissF P Zuspan
Feb 26, 1986·The American Journal of Cardiology·P K ZachariahK K Simpson
Jan 15, 1985·American Journal of Obstetrics and Gynecology·J M MoutquinN Pelland
Jul 15, 1985·American Journal of Obstetrics and Gynecology·J F Clapp
Nov 1, 1973·The Journal of Clinical Investigation·N F GantP C MacDonald
Sep 1, 1974·American Journal of Obstetrics and Gynecology·N F GantP C MacDonald
Dec 1, 1966·Clinical Obstetrics and Gynecology·L C Chesley
May 1, 1982·Clinical and Experimental Pharmacology & Physiology·L J BeilinL Davidson
Oct 1, 1993·British Journal of Obstetrics and Gynaecology·P M KyleC W Redman
Aug 1, 1961·American Journal of Obstetrics and Gynecology·R ABDUL-KARIM, S ASSALIN

❮ Previous
Next ❯

Citations

Nov 20, 2008·Archives of Gynecology and Obstetrics·Finn Friis LauszusJoachim G Klebe
Apr 29, 1999·Current Opinion in Obstetrics & Gynecology·D O Anumba, S C Robson
Jun 11, 2002·Blood Pressure Monitoring·J A StaessenUNKNOWN Participants of the 2001 Consensus Conference on Ambulatory Blood Pressure Monitoring
Feb 3, 2005·Blood Pressure Monitoring·Ramón C Hermida, Diana E Ayala
Jan 19, 2005·The Journal of Clinical Hypertension·Thomas G Pickering
Jul 18, 2000·Occupational and Environmental Medicine·J A StaessenR H Fagard
Aug 24, 2001·Journal of Hypertension·M A BrownL McHugh
Apr 13, 2004·Journal of Hypertension·Ramón C HermidaManuel Iglesias
Apr 17, 2010·Journal of Hypertension·Ramón C Hermida, Diana E Ayala
Nov 15, 2011·Journal of Hypertension·Fabio AngeliPaolo Verdecchia
Aug 10, 2013·Advances in Chronic Kidney Disease·Andrea G Kattah, Vesna D Garovic
Nov 9, 2015·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Alfonso Otero GonzálezLuis López Sánchez
Jul 31, 2007·Advanced Drug Delivery Reviews·Ramón C HermidaFrancesco Portaluppi
Sep 25, 2009·Paediatric and Perinatal Epidemiology·Mary Lou ThompsonRaymond S Miller
May 9, 2013·Clinical and Experimental Pharmacology & Physiology·Mark A Brown
Apr 22, 2004·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A L TranquilliA Corradetti
Sep 26, 2012·Chronobiology International·Diana E Ayala, Ramón C Hermida
Sep 26, 2012·Chronobiology International·Diana E AyalaRamón C Hermida
Sep 25, 2001·American Journal of Obstetrics and Gynecology·M A BrownM Jones
May 21, 2004·Expert Review of Cardiovascular Therapy·Ramón C Hermida, Diana E Ayala
Mar 11, 2004·The Journal of Clinical Hypertension·Ramomicronn C HermidaManuel Iglesias
May 25, 2002·Chronobiology International·Ramón C HermidaCarlos Calvo
Jul 25, 2000·Chronobiology International·J R Fernändez, R C Hermida
Jan 4, 2003·Chronobiology International·Ramón C HermidaDiana E Ayala

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.